Findings from a 12-month clinical follow-up.
-
Are non-steroidal anti-inflammatory drugs safe in acute myopericarditis? -
Researchers say guidelines for gabapentinoid treatment in young people may need review.
-
Guidelines for breast implant-associated anaplastic large-cell lymphoma Guidelines prepared by the UK National Co-ordinating Committee of Breast Pathology.
-
Healthcare professionals should direct patients to select apps with validated information, say researchers.
-
Increasing coverage of anti-hypertensive medications to 70 per cent alone would delay 39.4 million deaths.
-
ADA 2019—What are the optimal BP targets in T1D? Findings support lower targets in young adults than the ADA recommends.
-
ADA 2019—Total physical activity counts are tied to higher insulin sensitivity Results seen in adults with IGT or untreated newly diagnosed T2D.
-
ADA 2019—Lower BMI is tied to increased dementia risk after T2D diagnosis Weight loss and gain are both linked to increased dementia risk, too.
-
ADA 2019—Lifestyle intervention reduces CVD, microvascular disease risk in IGT 6+-year delay in T2D onset leads to benefit.
-
ADA 2019—Vitamin D disappoints yet again for T2D Supplementation offers no protective benefit.
-
ADA 2019—Beta-cell function loss is not always permanent T2D remission reported in DiRECT.
-
NAFLD ups DM risk in normal-weight adults Risk is higher than in heavy patients without NAFLD.
-
Weaning from mechanical ventilation is more successful after brief pressure-support trial Longer trial with T-piece ventilation led to fewer successful extubations, higher mortality.
-
Parkinson disease: behavioral therapy is tied to reduced OAB symptoms Nonpharmacological treatment could reduce the risk for cognitive impairment.